Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation
- PMID: 38728999
- DOI: 10.1016/j.pec.2024.108293
Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation
Abstract
Objective: To evaluate a nurse-led decision coaching programme aiming to redistribute health professionals' tasks to support immunotherapy decision-making in people with multiple sclerosis (MS).
Methods: Cluster-randomised controlled trial with an accompanying mixed methods process evaluation (2014 - 2018). We planned to recruit 300 people with clinically isolated syndrome or relapsing-remitting MS facing immunotherapy decisions in 15 clusters across Germany. Participants in the intervention clusters received up to three decision coaching sessions by a trained nurse and access to an evidence-based online information platform. In the control clusters, participants also had access to the information platform. The primary outcome was informed choice after six months, defined as good risk knowledge and congruent attitude and uptake.
Results: Twelve nurses from eight clusters participated in the decision coaching training. Due to insufficient recruitment, the randomised controlled trial was terminated prematurely with 125 participants (n = 42 intervention clusters, n = 83 control clusters). We found a non-significant difference between groups for informed choice favouring decision coaching: odds ratio 1.64 (95% CI 0.49-5.53).
Conclusions: Results indicate that decision coaching might facilitate informed decision-making in MS compared to providing patient information alone.
Practice implications: Barriers have to be overcome to achieve structural change and successful implementation.
Keywords: Decision coaching; Immunotherapy; Multiple sclerosis; Shared decision-making.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest AR, EV, SK, GA, KL and JP declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. CH declares the following financial interests/personal relationships which may be considered as potential competing interests: CH has received research grants from Merck, Novartis and Roche.
Similar articles
-
Understanding how and under what circumstances decision coaching works for people making healthcare decisions: a realist review.BMC Med Inform Decis Mak. 2022 Oct 8;22(1):265. doi: 10.1186/s12911-022-02007-0. BMC Med Inform Decis Mak. 2022. PMID: 36209086 Free PMC article. Review.
-
Decision coaching for people making healthcare decisions.Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013385. doi: 10.1002/14651858.CD013385.pub2. Cochrane Database Syst Rev. 2021. PMID: 34749427 Free PMC article. Review.
-
Nurse-led coaching of shared decision-making for women with ductal carcinoma in situ in breast care centers: A cluster randomized controlled trial.Int J Nurs Stud. 2019 May;93:141-152. doi: 10.1016/j.ijnurstu.2019.01.013. Epub 2019 Feb 8. Int J Nurs Stud. 2019. PMID: 30925280 Clinical Trial.
-
Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluation.Int J Nurs Stud. 2018 Feb;78:26-36. doi: 10.1016/j.ijnurstu.2017.08.011. Epub 2017 Aug 26. Int J Nurs Stud. 2018. PMID: 28982479 Clinical Trial.
-
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.Trials. 2015 Mar 21;16:106. doi: 10.1186/s13063-015-0611-7. Trials. 2015. PMID: 25872529 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical